drugset / Trial / NCT05288179

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

NCT05288179

Phase 3 Recruiting 272 enrolled Beijing Continent Pharmaceutical Co, Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a randomized, double-blind, placebo-controlled, multicenter clinical study. The main purpose of this study was to confirm the efficacy and safety of pirfenidone capsules in the treatment of pneumoconiosis.

Timeline

Start
2022-06-07
Primary completion
2026-09-30
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pirfenidone Small molecule

Indications